BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90

K Lundgren, H Zhang, J Brekken, N Huser… - Molecular cancer …, 2009 - AACR
Inhibition of heat shock protein 90 (Hsp90) results in the degradation of oncoproteins that
drive malignant progression, inducing cell death, making Hsp90 a target of substantial …

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

L Neckers, K Neckers - Expert opinion on emerging drugs, 2002 - Taylor & Francis
Heat-shock protein 90 (Hsp90) is a molecular chaperone whose association is required for
the stability and function of multiple mutated, chimeric and overexpressed signalling proteins …

Heat shock protein 90 as a drug target: some like it hot

U Banerji - Clinical Cancer Research, 2009 - AACR
Abstract Heat shock protein 90 (HSP90) is a ubiquitously expressed chaperone that is
involved in the posttranslational folding and stability of proteins. Inhibition at the NH2 …

Hsp90 inhibitors as novel cancer chemotherapeutic agents

L Neckers - Trends in molecular medicine, 2002 - cell.com
Abstract Heat shock protein 90 (Hsp90) is a molecular chaperone whose association is
required for the stability and function of multiple mutated, chimeric and over-expressed …

Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions

DS Hong, U Banerji, B Tavana, GC George… - Cancer treatment …, 2013 - Elsevier
Due to the critical role of heat shock protein 90 (HSP90) in regulating the stability, activity
and intracellular sorting of its client proteins involved in multiple oncogenic processes …

Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

A Younes, GV Georgakis - Future oncology, 2005 - Taylor & Francis
Heat-shock protein 90 (HSP90) has diverse functions in mammalian cells. It acts as
molecular chaperone, together with several co-chaperone molecules (such as Hop, Hip …

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics–an update

L Neckers, K Neckers - Expert opinion on emerging drugs, 2005 - Taylor & Francis
Heat-shock protein 90 (Hsp90) is a molecular chaperone whose association is required for
stability and function of a growing number of signalling proteins that have been implicated in …

Preclinical antitumor activity of the orally available heat shock protein 90 inhibitor NVP-BEP800

AJ Massey, J Schoepfer, PA Brough, J Brueggen… - Molecular cancer …, 2010 - AACR
Abstract Heat shock protein 90 (Hsp90) is a ubiquitously expressed molecular chaperone
with ATPase activity involved in the conformational maturation and stability of key signaling …

Heat shock protein 90

L Neckers, SP Ivy - Current opinion in oncology, 2003 - journals.lww.com
Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer
cells to eventually evade the toxic effects of most molecularly targeted agents. The …

Heat shock protein 90: the cancer chaperone

L Neckers - Heat Shock Proteins in Cancer, 2007 - Springer
Abstract Heat shock protein 90 (Hsp90) is a molecular chaperone required for the stability
and function of a number of conditionally activated and/or expressed signaling proteins, as …